For example, Park, Younghee et al. demonstrated the prognostic value of the association between HDAC6 and Hsp90 in patients with early-stage breast cancer and proposed a new approach to target HDAC6 and Hsp90 in the clinical treatment of breast cancer (Park et al. 2015). Here, HSP90AA1 is linked to breast cancer.